C section News and Research

RSS

Tax treaty with U.S. will pave way for investment in Canadian biotechnology firms, says BIOTECanada

Removing administrative barriers under the Canada-US Tax Treaty for investors such as non-resident venture capital funds are a welcome change, and ease the way for investment in Canadian biotechnology firms according to trade industry association BIOTECanada.

5 Mar 2010

Study sheds light on how CL-HA stimulates collagen repair in skin

In the U.S. and around the world, the popularity of minimally invasive cosmetic procedures continues to increase. Soft tissue injectables, also known as dermal fillers, are popular procedures that improve the appearance of aging and sun-damaged skin by restoring lost volume and filling lines.

5 Mar 2010

Second AACR cancer research conference to be hosted in Dead Sea, Jordan

The second American Association for Cancer Research Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic provides attendees with an overview of the most advanced cancer research in a variety of fields, including the tumor microenvironment, microRNAs, signal transduction and novel therapeutic development.

5 Mar 2010

White House unveils new health care legislation that leaves abortion funding intact

Today the White House unveiled new health care legislation that leaves the Senate abortion funding intact. When confronted with this fact by Minority Leader John Boehner, President Obama dismissed fact as mere talking points and "untrue." Speaker Pelosi continued this falsehood when she insisted that the health bills do not fund abortion.

4 Mar 2010

CPEX Pharmaceuticals' fourth-quarter 2009 revenues up 23%

CPEX Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2009. For the quarter CPEX reported revenues of $5.2 million and a net loss of $498,000. For the year CPEX reported revenues of $18.7 million and a net loss of $3.0 million.

3 Mar 2010

Major sports arenas in Europe have no adequate equipment, procedures to save spectators who suffer heart attacks

Too many major sports arenas in Europe do not have adequate equipment and procedures in place to save the lives of spectators who suffer heart attacks while watching a sporting event, according to new research published online today (Wednesday 3 March) in the European Heart Journal.

3 Mar 2010

Diabetics at risk: Nova Scotia limits pharmacare coverage of blood glucose test strips

The Nova Scotia government's decision to limit Pharmacare coverage of blood glucose test strips for some diabetes patients places a significant financial and health burden on these Nova Scotians and violates the fundamental principle that patients and their healthcare professionals should be able to determine how to manage treatment.

3 Mar 2010

CFAS supports the provision of publicly funded IVF and ICSI treatment across Canada

The Canadian Fertility and Andrology Society supports fully the provision of publicly funded in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) treatment across Canada. Infertility has been defined by the World Health Organization as a disease of the reproductive system defined by the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse.

3 Mar 2010

State roundup: Mass. hospital controversy, Iowa and Utah consider coverage expansions

The state appealed to the federal government yesterday to help Massachusetts hospitals that care for disproportionately high numbers of lower-income patients who receive state-sponsored health insurance. Governor Deval Patrick is asking the Obama administration for $216 million for Cambridge Health Alliance, the state's only public acute-care hospital, and another $115 million for six private hospitals with high Medicaid patient populations

3 Mar 2010

HTDS reports Gross Revenues of $5.39M for Fiscal Year ended December 31, 2009

Hard to Treat Diseases (http://www.htdsmedical.com) and its China based subsidiary Mellow Hope update shareholders on the company's 2009 revenues and profits.

2 Mar 2010

Cleveland HeartLab completes $3.0M fundraising round

Cleveland HeartLab LLC (CHL) today announced that it has completed a $3.0-million fundraising round. The company’s new shareholders include local business leaders, and Glengary LLC, Second Generation Ltd. and Zapis Capital Group LLC.

2 Mar 2010

Use of at-home medical devices can help patients and physicians efficiently manage chronic conditions

The use of at-home medical devices to connect doctors and patients via the Internet can help patients and their physicians work more efficiently together to manage chronic conditions, according to research at Cleveland Clinic.

2 Mar 2010

Latest FCC edition includes standards covering quality and purity for 1,100 food ingredients

New and updated quality standards for ingredients used in functional foods and a host of other food products manufactured, sold and consumed every day are included in the newly released seventh edition of the Food Chemicals Codex. Published by the U.S. Pharmacopeial Convention, the FCC is an internationally recognized compendium of standards that helps ensure the identity, quality, purity and consistency of food ingredients.

2 Mar 2010

Canyon Pharmaceuticals announces the availability of Iprivask inhibitor for prevention of DVT

Canyon PharmaceuticalsTM (www.canyonpharma.com) today announced the availability of Iprivask (desirudin for injection), the first direct thrombin inhibitor (DTI) approved in the United States by the Food and Drug Administration for the prevention of deep vein thrombosis (DVT), which may lead to pulmonary embolism in patients undergoing elective hip replacement surgery.

2 Mar 2010

Joint Chiefs Chair visits Haiti to examine aid response

Joint Chiefs of Staff Chair Mike Mullen, who is President Barack Obama's top military adviser, visited Haiti over the weekend to examine relief and rebuilding efforts and meet with local leaders, Agence France-Presse reports. It was his first visit to the country after the earthquake, according to AFP.

2 Mar 2010

Getting pregnant the "traditional" way or by assisted reproduction does not affect birthing process or the baby

Whether a women gets pregnant the "traditional" way or by assisted reproduction has no effect on the birthing process itself or the baby, researchers at the Norwegian University of Science and Technology (NTNU) have found.

2 Mar 2010

While Congress debates, health costs continue steep rise

The New York Times' "Week in Review" section features a story that begins: "Suppose Congress and President Obama fail to overhaul the system now, or just tinker around the edges, or start over, as the Republicans propose. ... Then 'my health care' stays the same, right? Far from it, health policy analysts and economists of nearly every ideological persuasion agree. The unrelenting rise in medical costs is likely to wreak havoc within the system and beyond it. ... Even those families that enjoy generous insurance now are likely to see the cost of those benefits escalate.

1 Mar 2010

Isis Pharmaceuticals reports revenues of $32.3M for fourth-quarter 2009

Isis Pharmaceuticals, Inc. today announced its 2009 financial results and reviewed the highlights of the year. Isis achieved its 2009 financial guidance with pro forma net income of $166.9 million and a pro forma net operating loss (NOL) of $14.2 million compared with its guidance for the year of pro forma net income of more than $145 million and a pro forma NOL in the low to mid $20 million range. Isis also achieved its cash guidance by ending 2009 with $574.3 million of cash, cash equivalents and short-term investments significantly in excess of the $550 million projected.

1 Mar 2010

Astellas Pharma to acquire OSI Pharmaceuticals for $3.5 billion on fully diluted basis

Astellas Pharma Inc., a global pharmaceutical company, will commence a tender offer to acquire all outstanding shares of common stock of OSI Pharmaceuticals for $52.00 per share in cash, or an aggregate of approximately $3.5 billion on a fully diluted basis.

1 Mar 2010

MedQuist integrates DEP with new features of Epic Systems' Hyperspace Client

MedQuist Inc., a leading provider of technology-enabled clinical documentation services, is integrating with Epic Systems Corporation within its Hyperspace environment to offer a solution that integrates "partial dictations" with the template-based clinical documentation process, enabling physicians to complete the Electronic Health Record (EHR) without changing their documentation workflow.

27 Feb 2010

C section News and Research

Tax treaty with U.S. will pave way for investment in Canadian biotechnology firms, says BIOTECanada

Study sheds light on how CL-HA stimulates collagen repair in skin

Second AACR cancer research conference to be hosted in Dead Sea, Jordan

White House unveils new health care legislation that leaves abortion funding intact

CPEX Pharmaceuticals' fourth-quarter 2009 revenues up 23%

Major sports arenas in Europe have no adequate equipment, procedures to save spectators who suffer heart attacks

Diabetics at risk: Nova Scotia limits pharmacare coverage of blood glucose test strips

CFAS supports the provision of publicly funded IVF and ICSI treatment across Canada

State roundup: Mass. hospital controversy, Iowa and Utah consider coverage expansions

HTDS reports Gross Revenues of $5.39M for Fiscal Year ended December 31, 2009

Cleveland HeartLab completes $3.0M fundraising round

Use of at-home medical devices can help patients and physicians efficiently manage chronic conditions

Latest FCC edition includes standards covering quality and purity for 1,100 food ingredients

Canyon Pharmaceuticals announces the availability of Iprivask inhibitor for prevention of DVT

Joint Chiefs Chair visits Haiti to examine aid response

Getting pregnant the "traditional" way or by assisted reproduction does not affect birthing process or the baby

While Congress debates, health costs continue steep rise

Isis Pharmaceuticals reports revenues of $32.3M for fourth-quarter 2009

Astellas Pharma to acquire OSI Pharmaceuticals for $3.5 billion on fully diluted basis

MedQuist integrates DEP with new features of Epic Systems' Hyperspace Client

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News